Glucosamine is not invariably effective for osteoarthritis, and its use should be approached with a degree of realism
Correspondence:
- 1.
- Felson DT. Epidemiology of osteoarthritis. In: Brandt KD, DohertyM, Lohmander LS, editors. Osteoarthritis. New York: OxfordUniversity Press, 1998.
- 2.
- Brooks PM, Hart JAL. The Bone and Joint Decade 2000-2010. Med JAust 2000; 172: 307-308.
- 3.
- Altman RD. Criteria for classification of clinicalosteoarthritis. J Rheum 1991; 18: 10-11.
- 4.
- Altman RD, Hochberg M, Murphy WA Jr, et al. Atlas of individualradiographic features in osteoarthritis. OsteoarthritisCartilage 1995; 3(Suppl A): 3-70.
- 5.
- Osteoarthritis Research Society (OARS). Task Force Report:Design and Conduct of Clinical Trials of Patients withOsteoarthritis: Recommendations from a Task Force of theOsteoarthritis Research Society. OsteoarthritisCartilage 1996; 4: 217-243.
- 6.
- Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set ofoutcome measures for future phase III clinical trials in knee, hip andhand osteoarthritis. Consensus development in OMERACT III. JRheumatol 1997; 24: 799-802.
- 7.
- Dougados M, LeClaire P, van der Heijde D, et al. Response criteriafor clinical trials on osteoarthritis of the knee and hip: a report ofthe Osteoarthritis Research Society International StandingCommittee for Clinical Trials Response Criteria Initiative.Osteoarthritis Cartilage 2000; 8: 395-403.
- 8.
- McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine andchondroitin for treatment of osteoarthritis: a systematic qualityassessment and meta-analysis. JAMA 2000, 283: 1469-1475.
- 9.
- Hochberg M, Altman R, Brandt K, et al. Recommendations for themedical management of osteoarthritis of the hip and knee. 2000update. Arthritis Rheum 2000; 43: 1905-1915.
- 10.
- Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety ofglucosamine sulfate versus ibuprofen in patients with kneeosteoarthritis. Arzneimittelforschung 1998; 48: 469-474.
- 11.
- Towheed TE, Anastassiades TP. Glucosamine and chondroitin fortreating symptoms of osteoarthritis: evidence is widely touted butincomplete. JAMA 2000; 283: 1483-1484.
- 12.
- Towheed TE, Anastassiades TP, Shea B, et al. Glucosamine therapyfor treating osteoarthritis (Cochrane Review) [abstract]. In:The Cochrane Library, 2, 2001. Oxford: Update Software.
- 13.
- Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects ofglucosamine sulphate on osteoarthritis progression: a randomised,placebo-controlled clinical trial. Lancet 2001; 357:251-256.
- 14.
- Chard J, Dieppe P. Glucosamine for osteoarthritis: magic, hype,or confusion? Lancet; 2001, 322: 1439-1440.
- 15.
- March L, Irwig L, Schwarz J, et al. N of 1 trials comparing anon-steroidal anti-inflammatory drug with paracetamol inosteoarthritis. BMJ 1994; 309: 1041-1045.
- 16.
- Rovati LC, Annefeld M, Giacovelli G, et al. Glucosamine inosteoarthritis [letter]. Lancet 1999; 354: 1640.
Online responses are no longer available. Please refer to our instructions for authors page for more information.